People with insulin resistance and type 2 diabetes appear to be at an increased risk of developing plaques in the brain that are associated with Alzheimer’s disease, according to new research published in the August 25, 2010, issue of Neurology® , the medical journal of the American Academy of Neurology.
Insulin resistance, or the stage before diabetes, happens when insulin, a hormone in the body, becomes less (more…)
Aggressive control of glycosylated hemoglobin (HbA1c) levels in patients with diabetes and end-stage renal disease (ESRD) is not associated with lower mortality, according to research published in the Clinical Journal of the American Society of Nephrology.
Researchers from the Joslin Diabetes Center in Boston suggested that clinicians avoid aggressive glucose management and instead focus on the recommended HbA1c level of under 7 percent (more…)